Article Details
Retrieved on: 2021-08-02 20:25:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... 1/2 clinical trial of AOC 1001, an antibody designed to reduce levels of DMPK, the disease-related mRNA, in patients with myotonic dystrophy.
Article found on: www.marketwatch.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here